REPORT ID 1672

China Blood Plasma Fractionation Market Research Report 2017

Publish Date
06-Dec-17
Pages
107
Format
Electronic (PDF)

The global Blood Plasma Fractionation market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Blood Plasma Fractionation development status and future trend in China, focuses on top players in China, also splits Blood Plasma Fractionation by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    GE Healthcare
    Pall Corporation
    Baxter
    CSL
    Grifols
    Octapharma
    BPL
    Kedrion
    Mitsubishi Tanabe
    CBOP
    RAAS
    Hualan Bio

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Albumin
    Immune Globulin
    Coagulation Factor

On the basis of the end users/application, this report covers
    Immunity
    Therapy
    Surgery

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Blood Plasma Fractionation Market Research Report 2017
1 Blood Plasma Fractionation Overview
    1.1 Product Overview and Scope of Blood Plasma Fractionation
    1.2 Classification of Blood Plasma Fractionation by Product Category
        1.2.1 China Blood Plasma Fractionation Sales (K Units) Comparison by Type (2012-2022)
        1.2.2 China Blood Plasma Fractionation Sales (K Units) Market Share by Type in 2016
        1.2.3 Albumin
        1.2.4 Immune Globulin
        1.2.5 Coagulation Factor
    1.3 China Blood Plasma Fractionation Market by Application/End Users
        1.3.1 China Blood Plasma Fractionation Sales (K Units) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Immunity
        1.3.3 Therapy
        1.3.4 Surgery
    1.4 China Blood Plasma Fractionation Market by Region
        1.4.1 China Blood Plasma Fractionation Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Blood Plasma Fractionation Status and Prospect (2012-2022)
        1.4.3 East China Blood Plasma Fractionation Status and Prospect (2012-2022)
        1.4.4 Southwest China Blood Plasma Fractionation Status and Prospect (2012-2022)
        1.4.5 Northeast China Blood Plasma Fractionation Status and Prospect (2012-2022)
        1.4.6 North China Blood Plasma Fractionation Status and Prospect (2012-2022)
        1.4.7 Central China Blood Plasma Fractionation Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Blood Plasma Fractionation (2012-2022)
        1.5.1 China Blood Plasma Fractionation Sales (K Units) and Growth Rate (%)(2012-2022)
        1.5.2 China Blood Plasma Fractionation Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Blood Plasma Fractionation Market Competition by Players/Manufacturers
    2.1 China Blood Plasma Fractionation Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Blood Plasma Fractionation Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Blood Plasma Fractionation Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.4 China Blood Plasma Fractionation Market Competitive Situation and Trends
        2.4.1 China Blood Plasma Fractionation Market Concentration Rate
        2.4.2 China Blood Plasma Fractionation Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Types

3 China Blood Plasma Fractionation Sales and Revenue by Region (2012-2017)
    3.1 China Blood Plasma Fractionation Sales (K Units) and Market Share by Region (2012-2017)
    3.2 China Blood Plasma Fractionation Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Blood Plasma Fractionation Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Blood Plasma Fractionation Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Blood Plasma Fractionation Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Blood Plasma Fractionation Price (USD/Unit) by Type (2012-2017)
    4.4 China Blood Plasma Fractionation Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Blood Plasma Fractionation Sales (K Units) and Market Share by Application (2012-2017)
    5.2 China Blood Plasma Fractionation Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Blood Plasma Fractionation Players/Suppliers Profiles and Sales Data
    6.1 GE Healthcare
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GE Healthcare Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pall Corporation
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pall Corporation Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Baxter
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Baxter Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 CSL
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 CSL Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Grifols
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Grifols Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Octapharma
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 BPL
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 BPL Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Kedrion
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Mitsubishi Tanabe
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Mitsubishi Tanabe Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 CBOP
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Blood Plasma Fractionation Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 CBOP Blood Plasma Fractionation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 RAAS
    6.12 Hualan Bio

7 Blood Plasma Fractionation Manufacturing Cost Analysis
    7.1 Blood Plasma Fractionation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Blood Plasma Fractionation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Blood Plasma Fractionation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Blood Plasma Fractionation Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Blood Plasma Fractionation Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Blood Plasma Fractionation Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Blood Plasma Fractionation Sales (K Units) Forecast by Type (2017-2022)
    11.3 China Blood Plasma Fractionation Sales (K Units) Forecast by Application (2017-2022)
    11.4 China Blood Plasma Fractionation Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List